Gene: MCTS2
Official Full Name: MCTS family member 2provided by HGNC
Gene Summary: This locus represents a retrogene copy of MCTS1 (GeneID:28985) and contains an ORF similar to that parent gene. This locus is situated in a differentially methylated region (DMR) and transcripts in this region are imprinted. [provided by RefSeq, Nov 2021]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16285 | MCTS2 Knockout cell line (HeLa) | Human | MCTS2 | 1:3~1:6 | Negative | Online Inquiry |
KO16286 | MCTS2 Knockout cell line (HCT 116) | Human | MCTS2 | 1:2~1:4 | Negative | Online Inquiry |
KO16287 | MCTS2 Knockout cell line (HEK293) | Human | MCTS2 | 1:3~1:6 | Negative | Online Inquiry |
KO16288 | MCTS2 Knockout cell line (A549) | Human | MCTS2 | 1:3~1:4 | Negative | Online Inquiry |
MCTS2 Gene Knockout Cell Lines are genetically modified cell lines featuring targeted deletions of the MCTS2 gene, which encodes for a protein involved in the metabolic regulation of cells. These specialized cell lines are particularly useful in elucidating the role of the MCTS2 protein in various biological processes, including cellular metabolism, signaling pathways, and tumorigenesis. By combining CRISPR/Cas9 technology and rigorous genetic screening, these cell lines facilitate the investigation of specific gene functions and their contributions to health and disease.
The key function of MCTS2 Gene Knockout Cell Lines lies in their utility for functional genomics studies. Researchers can employ these models to dissect metabolic pathways affected by MCTS2 deficiency, leading to insights into metabolic disorders or cancer metabolism. This capability supports the development of innovative therapeutic strategies, as understanding the metabolic alterations induced by MCTS2 knockout may reveal potential targets for intervention.
The scientific importance of these knockout cell lines extends to applications in both basic research and clinical settings. In a research environment, they serve as a valuable tool for studying gene function, drug responses, and metabolic assays, while in clinical contexts, they can aid in the development of personalized medicine approaches by identifying how specific metabolic dysregulations influence patient outcomes.
Compared to alternative models, MCTS2 Gene Knockout Cell Lines offer superior specificity in targeting the MCTS2 gene, minimizing off-target effects commonly associated with other genetic modification techniques. The precision CRISPR/Cas9 approach not only enhances the reliability of experimental results but also provides researchers with well-characterized knockouts, ensuring reproducibility of data.
This product proves invaluable for researchers and clinicians who seek to explore the intricate interplay between genes and metabolic pathways. MCTS2 Gene Knockout Cell Lines are essential for those aiming to push the boundaries of scientific understanding in metabolism-related fields. Our company specializes in producing high-quality, validated genetic models, tailored for rigorous scientific inquiries and advancing biotechnology. By choosing our products, you are investing in innovation that drives progress in research and healthcare.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.